rxpertusa logo spacer rxpertusa wings
logo spacer spacer spacer
spacer home
about us
assessment tools
sample consult
contact us

red line

spacer spacer news

The latest Mainline newsletters for the General Public are listed here.


For healthcare professionals we have a Mainline newsletter in a Professional version here.

Printer Friendly


Volume 2 September 9, 2005 Number6

An Exclusive Continuing Education Publication of Acadiana Consultant Pharmacy Service
Author, Publisher, Editor-in Chief, Typesetter & Printer, Charles S. Feucht,PD,FASCP PharmD candidate

Medication News & Update

 Fentanyl caution (Duragesic)  - FDA has sent out an alert cautioning helathcare prescribers about assuring that their patients utilizxe this drug exactly as outlined in the monograoh because of increased mortality rates. Use the lowest effective dose and use only in patients previously treated with opiods. Do not use for short term pain management or after surgery. Be sure to advise patients that drug absorption may increase with fever or increase heat exposure.

PSA & Obesity -  Past studies have reported an increase risk of prostate cancer in in obese patients. Other studies show little or no association to obesity. It is now thought that obesity may actually result in artificially decreased PSA levels. This would make it difficlut for physicians to diagnose prostate cancer because of the suppression of PSA values in obese patients. For further details refer to Cancer 2005; 103: 1092-5.



Home ] [ About Us  ] [ Assessment Tools  ] [ Sample Consult  ]
Contact Us  ]

Copyright © www.rxpertusa.com. Designed by PcHousekeeping.com
  spacer spacer